Considering the heterogeneity and homogeneity of tumorigenesis, it is extremely significant to explore and evaluate novel prognostic or therapeutic targets, which could function as a paradigm in the systematic management era.
← all excerpts
A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma.
1
—
—